Bayer and BI have reported broadly similar efficacy outcomes for sevabertinib and Hernexeos in HER2-mutant NSCLC.

The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.

I know how destructive unchecked addiction can be. All the victims of the ongoing opioid crisis do, too. And this is about more than addiction — as when rare but real cases of myocarditis appeared in ...

But last week, those words took on the force of law. On Tuesday, Texas Attorney General Ken Paxton filed a lawsuit against ...

For fashion items and the basics, which is ahead in the style and value-for-money stakes? Click to tell us what YOU think of Gap and M&S ...

Neither Teva nor the FDA issued guidance on what to do with the recalled tablets. But according to GoodRx, anyone affected by ...

Localized supply chains are crucial for mitigating geopolitical risks and ensuring operational continuity in the biopharmaceutical sector. Regulatory harmonization enhances access to medicines, ...

A feud between the FDA's Vinay Prasad and his staff is threatening the future of the center that regulates vaccines, ...

If you're wondering how the title Bugonia connects to a movie about two conspiracy theorists who kidnap the head of a major ...

Blood pressure medication was recalled by the FDA. The prescription drug didn’t meet the agency’s standards for a lack of ...

The FDA’s effort to expedite reviews for drugs in line with the Trump administration’s priorities was greeted warmly by a ...

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices, ...